Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. [electronic resource]
Producer: 20170925Description: 1211-1220 p. digitalISSN:- 1474-5488
- Adenocarcinoma -- mortality
- Aged
- Androstadienes -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- mortality
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Male
- Mastectomy
- Middle Aged
- Postmenopause
- Tamoxifen -- therapeutic use
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.